Articles: 26.19 5 October 2015

Dulaglutide: a once-weekly GLP-1 for type 2 diabetes

Dulaglutide is a once-weekly GLP-1 receptor agonist for the treatment of type 2 diabetes. Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Professor Stephen Bain discusses its place in therapy.
Dulaglutide a once-weekly GLP-1 for type 2 diabetes

More details...

Fungal skin infections: current approaches to management

The dermatophyte skin infections tinea capitis, tinea pedis and onychomycosis are common and challenging to treat. This review focuses on key points and recent guidelines on the diagnosis and management of fungal skin infections.
Fungal skin infections current approaches to management

More details...

Learning from medicine related safety incidents

This is the first in a series of eight articles that will discuss the recommendations pertaining to medication safety, and provide insights into their application and implications for practice.
Learning from medicine related safety incidents

More details...

Long-term antidepressant treatment: time for a review?

Antidepressant use in Western countries doubled between 2003 and 2013. By 2014, 11 per cent of adults in England were taking them, costing £280 million annually. While antidepressants can be used for pain and insomnia, the large majority are prescribed for depression and anxiety disorders.
Long-term …

More details...

New from NICE

Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism. Edoxaban (Lixiana) is, like rivaroxaban (Xarelto) and apixaban (Eliquis), an oral direct inhibitor of Factor Xa.
New from NICE

More details...

Trends in primary care prescribing, 2004–2014

Statistics from the Health and Social Care Information Centre give an overview of tends in prescribing over the past 10 years. Here we outline the main shifts in practice.
Trends in primary care prescribing

More details...

Web design and marketing agency Leamington Spa